Lumen, maker of a handheld metabolism measurement machine, introduced Thursday it had scooped up $62 million in Sequence B funding.
The spherical was led by Pitango Enterprise Capital with participation from Hanwha Group, Resolute Ventures, RiverPark Ventures, Unorthodox Ventures, Almeda Capital and Disruptive VC.
The corporate beforehand raised $8.5 million in 2019 in addition to a crowdfunding increase in 2018.
WHAT THEY DO
The startup affords a handheld, breathalyzer-like machine outfitted with a CO2 sensor. Customers breathe into the machine, and it analyzes whether or not the physique is burning fat or carbs for gasoline.
Lumen additionally supplies an app that collects that knowledge and supplies diet suggestions primarily based on outcomes. It additionally integrates with Apple HealthKit, Google Match and Garmin.
The corporate mentioned it has partnered with analysis establishments like Purdue College’s Whistler Middle for Carbohydrate Analysis, College of Toronto’s College of Kinesiology and Bodily Schooling and ARU Cambridge over the previous yr.
“Till now, finding out metabolism with the usual gear was difficult for each researchers and members. The information assortment was minimal and would require members to come back to a clinic for every measurement and a practitioner to research the outcomes,” Merav Mor, chief scientist and cofounder of Lumen, mentioned in an announcement. “Now researchers can simply acquire a number of knowledge factors from members and construct extra advanced analysis protocols that unveil new physiological findings.”
Lumen mentioned it plans to make use of the capital to develop its attain within the U.S. and worldwide, add new customized diet and way of life suggestions and help its analysis partnerships.
MARKET SNAPSHOT
There are a selection of different digital well being firms targeted on dietary steering, weight reduction or metabolic care.
Twin Well being pitches an AI-backed mannequin that goals to supply individualized diet, sleep and exercise tips to assist individuals stop and reverse metabolic illnesses like Sort 2 diabetes. It introduced a $140 million Sequence C increase in October final yr.
One other firm targeted on metabolic well being and weight reduction, Calibrate, introduced a $100 million Sequence B final yr.
Related well being tech firm Withings has additionally been increasing into diet suggestions with the acquisition of customized health and meal planning app 8fit.
